Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development.

The structural and functional development of the pulmonary system is dependent upon appropriate early vascularization of the embryonic lung. Our previous in vitro studies in a rat model indicated that insulin-like growth factor-I (IGF-I) is a potent angiogenic agent for fetal lung endothelial cells. To assess its role on human vascular lung development, we first examined the expression of IGF-I/II and IGF receptor type I (IGF-IR) in human embryonic and fetal lung tissues at 4-12 wk of gestation. Immunohistochemical and in situ hybridization studies revealed the presence of IGF-I/II-IGF-IR ligands and mRNA transcripts in embryonic lungs as early as 4 wk gestation. Immunotargeting using an anti-IGF-IR neutralizing antibody on human fetal lung explants demonstrated a significant blockade of IGF-IR signaling. Inactivation of IGF-IR resulted in a loss of endothelial cells, accompanied by dramatic changes in fetal lung explant morphology. Terminal transferase dUTP end-labeling assay and TEM studies of anti-IGF-IR-treated lungs demonstrated numerous apoptotic mesenchymal cells. Rat embryonic lung explant studies further validated the importance of the IGF-IGF-IR system for lung vascular development. These data provide the first demonstration of IGF-I/II expression in the human lung in early gestation and indicate that the IGF family of growth factors, acting through the IGF-IR, is required as a survival factor during normal human lung vascularization.

[1]  A. Grothey,et al.  The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors , 1999, Journal of Cancer Research and Clinical Oncology.

[2]  A. Tanswell,et al.  Antisense oligodeoxynucleotides targeting PDGF-B mRNA inhibit cell proliferation during embryonic rat lung development. , 1994, Development.

[3]  K. L. Moore,et al.  The Developing Human: Clinically Oriented Embryology , 1973 .

[4]  L. Ellis,et al.  Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. , 1998, Cancer research.

[5]  M. Post,et al.  Lung fluid restriction affects growth but not airway branching of embryonic rat lung. , 1995, The International journal of developmental biology.

[6]  D. Clemmons,et al.  Colocalization of insulin-like growth factor-binding protein with insulin-like growth factor I. , 1991, The American journal of physiology.

[7]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[9]  A. Tanswell,et al.  Insulin-like growth factor-I and type I insulin-like growth factor receptor in 85% O2-exposed rat lung. , 1996, The American journal of physiology.

[10]  D. Gaillard,et al.  In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development. , 1995, The International journal of developmental biology.

[11]  Insulin-Like Growth Factors , 1991 .

[12]  Kenneth P. Karey,et al.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. , 1988, Cancer research.

[13]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[14]  C. Heldin,et al.  Growth factors and their receptors. , 1989, Current opinion in cell biology.

[15]  R. Ertsey,et al.  Apoptosis in the development of rat and human fetal lungs. , 1998, American journal of respiratory cell and molecular biology.

[16]  A. Tanswell,et al.  The response of small vessel endothelial cells from fetal rat lung to growth factors. , 1991, Journal of developmental physiology.

[17]  A. Jetten.  Growth and differentiation factors in tracheobronchial epithelium. , 1991, The American journal of physiology.

[18]  J. Brody,et al.  Expression of insulin-like growth factor receptors 1 and 2 in the developing lung and their relation to epithelial cell differentiation. , 1995, American journal of respiratory cell and molecular biology.

[19]  V. Han,et al.  Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. , 1988, The Journal of clinical endocrinology and metabolism.

[20]  C. Tickle,et al.  Epithelial cell movements and interactions in limb, neural crest and vasculature. , 1999, Current Opinion in Genetics and Development.

[21]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[22]  K. L. Moore,et al.  The developing human , 1988 .

[23]  H. Lassmann,et al.  In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain , 2004, Acta Neuropathologica.

[24]  M. Post,et al.  PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[25]  F. Habib,et al.  The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  B. Christ,et al.  Embryonic angiogenesis: A review , 1996, Naturwissenschaften.

[27]  David Warburton,et al.  The molecular basis of lung morphogenesis , 2000, Mechanisms of Development.

[28]  H. Lassmann,et al.  Cellular Localization of Insulin-Like Growth Factor II mRNA in the Human Fetus and the Placenta: Detection with a Digoxigenin-Labeled cRNA Probe and Immunocytochemistry , 1998, Pediatric Research.

[29]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[30]  C. Ward,et al.  Structure and function of the type 1 insulin-like growth factor receptor , 2000, Cellular and Molecular Life Sciences CMLS.

[31]  D. Rappolee,et al.  Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. , 1992, Genes & development.

[32]  Takashi Suzuki,et al.  Analysis of Intrapulmonary Vessels and Epithelial-Endothelial Interactions in the Human Developing Lung , 2002, Laboratory Investigation.

[33]  M. Grant,et al.  Insulin‐like Growth Factor I as an Angiogenic Agent In Vivo and In Vitro Studies , 1993, Annals of the New York Academy of Sciences.

[34]  D. Sawyer,et al.  Early fetal development of lung vasculature. , 1997, American journal of respiratory cell and molecular biology.

[35]  H. Hansson,et al.  Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis. , 1989, Experimental and molecular pathology.